Approval · Notice of Compliance 33994 · 2024
DUOKOPT: Notice of Compliance 33994
Issued September 10, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 33994
- Date
- September 10, 2024
- Company
- Laboratoires ThéaClermont-Ferrand, Cedex 2, France
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph
- Canadian reference product
- COSOPT (Elvium Life Sciences)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| DUOKOPT | Not yet assigned | — |
Medicinal ingredients
- TIMOLOL MALEATE 5 MG per ML
- DORZOLAMIDE HYDROCHLORIDE 20 MG per ML